Geode Capital Management LLC Has $322.96 Million Position in Revvity, Inc. (NYSE:RVTY)

Geode Capital Management LLC boosted its holdings in Revvity, Inc. (NYSE:RVTY - Free Report) by 1.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 2,901,459 shares of the company's stock after buying an additional 37,666 shares during the period. Geode Capital Management LLC owned 2.38% of Revvity worth $322,958,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. Assetmark Inc. increased its position in Revvity by 3,700.0% during the 4th quarter. Assetmark Inc. now owns 266 shares of the company's stock worth $30,000 after purchasing an additional 259 shares in the last quarter. Millstone Evans Group LLC purchased a new stake in shares of Revvity during the fourth quarter valued at approximately $38,000. Continuum Advisory LLC lifted its position in shares of Revvity by 2,972.7% during the third quarter. Continuum Advisory LLC now owns 338 shares of the company's stock worth $43,000 after purchasing an additional 327 shares in the last quarter. MassMutual Private Wealth & Trust FSB grew its holdings in Revvity by 55.9% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 385 shares of the company's stock valued at $43,000 after purchasing an additional 138 shares in the last quarter. Finally, EverSource Wealth Advisors LLC boosted its holdings in Revvity by 33.5% in the fourth quarter. EverSource Wealth Advisors LLC now owns 522 shares of the company's stock valued at $58,000 after purchasing an additional 131 shares during the last quarter. 86.65% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Analysts Set New Price Targets

RVTY has been the topic of a number of research analyst reports. Barclays reduced their price objective on shares of Revvity from $140.00 to $110.00 and set an "overweight" rating on the stock in a research note on Thursday. Sanford C. Bernstein downgraded Revvity from an "outperform" rating to a "market perform" rating and set a $130.00 price target for the company. in a report on Friday, January 10th. KeyCorp lifted their price objective on shares of Revvity from $132.00 to $145.00 and gave the stock an "overweight" rating in a report on Monday, February 3rd. Bank of America upgraded shares of Revvity from a "neutral" rating to a "buy" rating and set a $138.00 price target on the stock in a research report on Friday, December 13th. Finally, Raymond James reiterated an "outperform" rating and issued a $145.00 target price (up from $140.00) on shares of Revvity in a research note on Monday, February 3rd. Four equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Revvity currently has an average rating of "Moderate Buy" and a consensus target price of $133.75.

Insider Transactions at Revvity

In other Revvity news, insider Joel S. Goldberg sold 15,170 shares of the business's stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $126.73, for a total value of $1,922,494.10. Following the transaction, the insider now owns 33,400 shares of the company's stock, valued at approximately $4,232,782. The trade was a 31.23 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.68% of the stock is owned by insiders.

Revvity Stock Down 9.7 %

NYSE RVTY traded down $9.79 on Thursday, reaching $91.55. The stock had a trading volume of 488,717 shares, compared to its average volume of 885,287. The company has a market capitalization of $11.00 billion, a price-to-earnings ratio of 41.44, a P/E/G ratio of 3.82 and a beta of 1.07. The business has a 50 day moving average price of $110.30 and a 200 day moving average price of $115.59. Revvity, Inc. has a 1 year low of $89.61 and a 1 year high of $129.50. The company has a current ratio of 3.60, a quick ratio of 3.03 and a debt-to-equity ratio of 0.41.

Revvity (NYSE:RVTY - Get Free Report) last released its earnings results on Friday, January 31st. The company reported $1.42 earnings per share for the quarter, beating the consensus estimate of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same period in the previous year, the firm earned $1.25 earnings per share. On average, analysts forecast that Revvity, Inc. will post 4.94 EPS for the current fiscal year.

Revvity Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Friday, April 18th will be paid a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.31%. The ex-dividend date is Thursday, April 17th. Revvity's dividend payout ratio is 12.67%.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.